{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-025565","form_type":"8-K","ticker":"PVLA","cik":"0001583648","company_name":"PALVELLA THERAPEUTICS, INC.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.638243+00:00","generated_at":"2026-05-31T10:55:23.158897+00:00","sec_items":["1.01","5.03","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pieris issues special voting preferred to Chairman to secure authorized share increase vote","bullets":["Issued 1 share of Series F Preferred to Chairman James Geraghty for $1 cash; preferred has 25M votes.","Preferred votes only on proposal to increase authorized common shares, in proportion to common votes.","No conversion, dividends, or liquidation rights; redeemable for $0.01 upon authorized share increase or Board order.","The authorized share increase is to facilitate the proposed merger with Palvella Therapeutics.","The preferred ensures a favorable vote on the authorized share increase, a key step in the merger."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-025565","json":"https://secwatch.observer/filing/0001437749-24-025565.json","markdown":"https://secwatch.observer/filing/0001437749-24-025565.md","text":"https://secwatch.observer/filing/0001437749-24-025565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583648/000143774924025565/0001437749-24-025565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/000143774924025565/pirs20240807_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:55:23.158897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}